Please click
 User   Pwd      Remember
Article Search: 
· Home
· About us
· Services
· Contact us
Info Resources
· Companies
· Institutes
· Science parks
· Life science news
· Company spotlight
· Taiwan bio report
· Feature articles
· Asia-Pacific events
· Investment corner
· Technology transfer
· Int'l biotech links
· Info resources search
· Job listings
· Log out
Previous  8 9 10 11 12 13 14 15 16 17 ... Total pages:251  Next 

Life Science News

(Taiwan) Containment begins as H7N9 spreads to Taiwan

(China Post, Taiwan)

25 April, 2013
Taiwan has its first confirmed case of H7N9 avian influenza, the Central Epidemic Command Center (CECC) announced yesterday.

Life Science News

(Taiwan) Work on H7N9 virus still in R&D stage: health official

(Focus Taiwan)

24 April, 2013
The Department of Health (DOH ) said Wednesday that work on the new H7N9 avian flu virus strain obtained from China is still in the research and development stage and that the DOH has invited local experts to discuss ways of combating the deadly flu.

Life Science News

(Taiwan) Bird Flu Strain Spreads as Taiwan Reports First H7N9 Infection


24 April, 2013
Taiwan confirmed an H7N9 bird flu infection in a traveler returning to the island from China, the first incidence of the killer virus spreading outside the mainland.

Life Science News

(Taiwan) FDA unveils pharmaceutical regulatory easing

(Taiwan Today)

23 April, 2013
Approvals for new drugs imported into Taiwan will be fast-tracked under a streamlined procedure announced April 22 by the ROC Food and Drug Administration.

Life Science News

(Taiwan) Advaxis and FusionVax sign MoU for the license of Advaxis' ADXS-HPV in Asia

(BiotechEast staff)

22 April, 2013
Advaxis, Inc., (OTCBB: ADXS), a developer of immunotherapies for cancer and infectious diseases, announced that it has entered into a Memorandum of Understanding (MoU) with FusionVax, Inc., under which Advaxis intends to exclusively license its lead clinical stage product candidate, ADXS-HPV, to Taiwan-based FusionVax for Asian markets.

Life Science News

(Taiwan) OK Biotech and Prodigy Diabetes Care announce cross-ownership deal

(BiotechEast staff)

16 April, 2013
US-based Prodigy Diabetes Care announced this week that its Taiwanese manufacturing partner, OK Biotech Co., Ltd., (GRETAI: 4155) had purchased a minority stake in the company, and Prodigy had in turn acquired substantial ownership of OK Biotech's publicly traded shares.

Life Science News

(Taiwan) New Taipei City launches biotech consortium

(Taiwan Today)

10 April, 2013
New Taipei City Government inaugurated a biotech development consortium April 10, further strengthening the metropolisí credentials as a leading industry hub in Taiwan.

Life Science News

(Taiwan) Taiwan Warily Eyes Spread Of H7N9 In Mainland China


18 April, 2013
Taiwan, the high-tech manufacturing hub that is home to globally important tech businesses such as TSMC, HTC and numerous Apple suppliers, is located only about 100 miles from the shore of mainland China, where the spread of new and deadly H7N9 bird flu has brought concerns about public health. Whatís the view of H7N9ís risks in Taiwan, and how is it affecting businesses? To learn more, I exchanged with David Silver, the president of BiotechEast, a pharmaceutical industry research company in Taipei. Excerpts follow.

Life Science News

(Taiwan) Tiny Taiwan Preps for Worst; H7N9 Vaccine Plan in Place


12 April, 2013
Taiwan is facing another pandemic influenza threat from China. It's deja vu all over again.

Life Science News

(Taiwan) Adimmune inks deal with Techdow

(Taipei Times)

3 April, 2013
Taiwanese vaccine manufacturer Adimmune Corp yesterday signed a cooperation pact with China-based Shenzhen Techdow Pharmaceutical Co Ltd to produce enoxaparin sodium injections, which are used to prevent and treat blood clots.



Taiwan Life Sciences Bulletin

Enter email address to receive free e-newsletter


Disclaimer and Privacy Policy